WuXi AppTec
Chinese public (bio)pharmaceutical, medical device and pharmaceutical services company
Nº Q8038871 ★★★
Rara · Organizaciones
WuXi AppTec
Chinese public (bio)pharmaceutical, medical device and pharmaceutical services company
WuXi AppTec Co., Ltd. (WuXi is pronounced as Wu-shee) is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Último precio
—
Precio mínimo
—
Mediana 7 d
—
Ventas 30 d
0
Rango 30 d
—
En circulación
0
Cotización
mediana
mín – máx
ventas
Sin ventas en el periodo
Ver tabla
| Fecha | mediana | Mín | Máx | ventas |
|---|
Historial de ventas
- Última venta
- —
- Media 30 d
- —
- Mínimo 30 d
- —
- Máximo 30 d
- —
- Ventas 7 d
- 0
- Ventas 30 d
- 0
Aún no hay ventas.
Ventas anónimas: sin comprador ni vendedor. Las cifras solo cuentan ventas entre jugadores.
En Wikipedia
Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.
WuXi AppTec Co., Ltd. (WuXi is pronounced as Wu-shee) is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe. Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer.
Texto: Wikipedia en inglés, CC BY-SA 4.0. ·
